文献速递皮肤肿瘤

儿童癌症幸存者的角质形成细胞癌:儿童癌症幸存者研究报告

Keratinocyte carcinomas in survivors of childhood cancer: A report from the childhood cancer survivor study.
PubMed 文献 · J Am Acad Dermatol · 2024-08-23

基于北美儿童癌症幸存者研究队列25,658名参与者,共发生1446例角质形成细胞癌、5363个病灶,93.5%为基底细胞癌。放疗使任何角质形成细胞癌发生率增加4.5倍、≥4个病灶发生率增加9.4倍,异基因和自体造血细胞移植分别增加3.4倍和2.3倍。作者认为该负担虽高但风险因素可预测,应指导筛查。

要点

  • 儿童癌症幸存者角质形成细胞癌负担高,平均发病年龄37.0岁,平均潜伏期25.7年
  • 放疗者任何角质形成细胞癌发生率增加4.5倍,≥4个病灶发生率增加9.4倍
  • 异基因与自体造血细胞移植分别增加3.4倍和2.3倍发生率,风险因素可指导筛查

核心结论

  • 儿童癌症幸存者角质形成细胞癌负担仍然很高,但风险因素可预测,应据此指导筛查。

研究设计与样本

  • 儿童癌症幸存者研究(CCSS)队列,纳入1970至1999年间北美诊断时<21岁、确诊后存活5年的癌症幸存者,共25,658名参与者。
  • 估算累积发病率,并用多变量模型评估幸存者特征与治疗相关特征对应的角质形成细胞癌相对发生率。

主要发现

  • 25,658名参与者中1446例发生5363个角质形成细胞癌病灶,93.5%为基底细胞癌,6.7%为鳞状细胞癌。
  • 患者平均年龄37.0岁(范围7.3–67.4),平均潜伏期25.7年;95.3%为白人,88.4%接受过放疗。
  • 平均病灶数为3.7个,26.1%的病例出现≥4个病灶。
  • 放疗使任何角质形成细胞癌的发生率增加4.5倍,使≥4个病灶的发生率增加9.4倍。
  • 异基因和自体造血细胞移植分别与角质形成细胞癌发生率增加3.4倍和2.3倍相关。

临床怎么用

  • 对儿童癌症幸存者,尤其接受过放疗或造血细胞移植者,应依据可预测的风险因素进行角质形成细胞癌筛查。

局限性

  • 部分数据为参与者自我报告,包括种族(未含皮肤光型)和既往病史,可能影响分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Childhood cancer survivors (CCS) are at increased risk for keratinocyte carcinomas (KC) however, the long-term incidence of single and multiple KC is not well established. OBJECTIVE: Identify risk factors and quantify KC cumulative incidence and multiple-incidence burden in CCS. METHODS: KC were identified among Childhood Cancer Survivor Study participants, a cohort of 5-year cancer survivors diagnosed <21 years of age between 1970 and 1999 in North America. Cumulative incidence was estimated and multivariable models assessed relative rates of KC associated with survivor and treatment characteristics. RESULTS: Among 25,658 participants, 1446 developed 5363 KC (93.5% basal cell carcinoma, 6.7% squamous cell carcinoma; mean age 37.0 years (range 7.3-67.4), mean latency 25.7 years; 95.3% White and 88.4% with radiotherapy). Mean lesion count was 3.7 with 26.1% experiencing ≥4. Radiotherapy imparted a 4.5-fold increase in the rate of any KC and 9.4-fold increase in the rate of ≥4 KC. Allogeneic and autologous hematopoietic cell transplant were associated with a 3.4- and 2.3-fold increased rate of KC, respectively. LIMITATIONS: Participant self-reporting of some data including race without skin phototype and past medical history may have impacted analysis. CONCLUSIONS: The burden of KC in CCS remains high, but predictable risk factors should guide screening.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Boull C, Chen Y, Im C, et al. Keratinocyte carcinomas in survivors of childhood cancer: A report from the childhood cancer survivor study. J Am Acad Dermatol. 2024. PMID: 39182687. doi:10.1016/j.jaad.2024.07.1520

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。